Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yossi Nishri

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Neurology and Neuroscience Reports|October 1, 2013
Cell-based reparative therapies for multiple sclerosisTamir Ben-Hur, Nina Fainstein, Yossi Nishri
Journal of Neuroinflammation|February 16, 2020
Systemic microbial TLR2 agonists induce neurodegeneration in Alzheimer's disease miceNeta Lax, Nina Fainstein, Yossi Nishri, et al.
Journal of Neuroimmunology|April 28, 2021
Modeling compartmentalized chronic immune-mediated demyelinating CNS disease in the Biozzi ABH mouseYossi Nishri, Nina Fainstein, Smadar Goldfarb, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2006
Suppression of Arabidopsis vesicle-SNARE expression inhibited fusion of H2O2-containing vesicles with tonoplast and increased salt toleranceYehoram Leshem, Naomi Melamed-Book, Olivier Cagnac, et al.
International Journal of Radiation Oncology, Biology, Physics|August 28, 2022
Diffusing Alpha-Emitters Radiation Therapy Promotes a Proimmunogenic Tumor Microenvironment and Synergizes With Programmed Cell Death Protein 1 BlockadeSara Del Mare, Yossi Nishri, Amit Shai, et al.
Molecular Neurobiology|October 29, 2019
Continuous Immune-Modulatory Effects of Human Olig2+ Precursor Cells Attenuating a Chronic-Active Model of Multiple SclerosisYossi Nishri, David Hampton, Etti Ben-Shushan, et al.
Frontiers in Oncology|October 14, 2022
Diffusing alpha-emitters radiation therapy in combination with temozolomide or bevacizumab in human glioblastoma multiforme xenograftsYossi Nishri, Maayan Vatarescu, Ishai Luz, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Neurology and Neuroscience Reports|October 1, 2013
Cell-based reparative therapies for multiple sclerosisTamir Ben-Hur, Nina Fainstein, Yossi Nishri
Journal of Neuroinflammation|February 16, 2020
Systemic microbial TLR2 agonists induce neurodegeneration in Alzheimer's disease miceNeta Lax, Nina Fainstein, Yossi Nishri, et al.
Journal of Neuroimmunology|April 28, 2021
Modeling compartmentalized chronic immune-mediated demyelinating CNS disease in the Biozzi ABH mouseYossi Nishri, Nina Fainstein, Smadar Goldfarb, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2006
Suppression of Arabidopsis vesicle-SNARE expression inhibited fusion of H2O2-containing vesicles with tonoplast and increased salt toleranceYehoram Leshem, Naomi Melamed-Book, Olivier Cagnac, et al.
International Journal of Radiation Oncology, Biology, Physics|August 28, 2022
Diffusing Alpha-Emitters Radiation Therapy Promotes a Proimmunogenic Tumor Microenvironment and Synergizes With Programmed Cell Death Protein 1 BlockadeSara Del Mare, Yossi Nishri, Amit Shai, et al.
Molecular Neurobiology|October 29, 2019
Continuous Immune-Modulatory Effects of Human Olig2+ Precursor Cells Attenuating a Chronic-Active Model of Multiple SclerosisYossi Nishri, David Hampton, Etti Ben-Shushan, et al.
Frontiers in Oncology|October 14, 2022
Diffusing alpha-emitters radiation therapy in combination with temozolomide or bevacizumab in human glioblastoma multiforme xenograftsYossi Nishri, Maayan Vatarescu, Ishai Luz, et al.
Pageof 1